Eli Lilly to Pull Cancer Drug From Market After Failed Study

📆 25/04/2019 19:00:00
📰 WSJ

⏱ Reading Time:
18 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 63%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Eli Lilly plans to withdraw its cancer drug Lartruvo from the market after a study showed it failed to prolong overall survival

Eli Lilly & Co. said Thursday it plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.

The company will establish an access program to allow some patients with soft-tissue sarcoma—a cancer that develops in connective tissue including muscle—to continue taking the drug with limited interruption after it’s withdrawn from the market. Lilly didn’t provide a specific timeline and said it’s working with health regulators on its plans.

Écrire un Commentaire

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Stock market fails to extend climb to records as energy-sector retreat weighsThe S&P 500 and the Nasdaq Composite indexes on Wednesday failed to extend their climb into record territory as a pullback in the mostly buoyant energy...
La source: MarketWatch - 🏆 3. / 97 Lire la suite »